Discover TRI's
History Mission Vision Values

Our mission, vision, and values are unified in a single goal, to simplify Risk-Based Quality Management (RBQM) for all clinical trials.

HISTORY

About TRI

Take a moment to explore TRI's history through our significant milestones. Since our establishment in 2013, we have been at the forefront of providing exceptional quality management solutions.

2013

Establishing our foundation in Cambridge, UK

In 2013, TRI marked its entry into the world of clinical trial quality management by opening our first office in the historic and intellectually vibrant city of Cambridge. This milestone symbolized our commitment to innovation and excellence, setting the stage for a future where research and technology converge to redefine industry standards.

2016

Introducing OPRA, a new era of monitoring

Our journey took a significant leap forward in 2016 with the launch of OPRA-CM, our centralized monitoring platform. Designed with precision and user experience in mind, OPRA-CM revolutionized how research data is monitored, ensuring higher quality, efficiency, and compliance in clinical trials. This innovation underscored our dedication to transforming research methodologies through smart technology.

2020

Further advancing risk management

In 2020, TRI once again pushed the boundaries of quality management by unveiling our advanced risk assessment and management tool, OPRA-RAM. This tool was developed to empower researchers to proactively identify, evaluate, and mitigate risks in their studies, ensuring the utmost integrity and reliability of research outcomes. This launch not only highlighted our ongoing commitment to safety and excellence but also set new benchmarks in research risk management.

Website Mission blue
MISSION

To make RBQM simple for all clinical trials

At TRI, our mission is to make Risk-Based Quality Management simple; making it accessible, understandable, and actionable for clinical trials of any scale and complexity. We develop innovative technologies and simplified solutions to empower research organizations and sponsors, ensuring the highest standards of trial integrity and participant safety.

VISION

Enhanced efficiency and patient safety for all trials

Our vision is to be the global catalyst for change in clinical research, where RBQM is not a regulatory burden, but a standard practice embraced for its simplicity and effectiveness. We envision a future where every clinical trial, regardless of size or scope, benefits from advanced, intuitive RBQM solutions, driving efficiencies, enhancing safety, and ultimately accelerating the delivery of life-saving treatments to those in need.

VALUES

Our core values are at the heart of our mission

Our values are the foundation of our mission to simplify RBQM for clinical trials. Listed below, these principles guide our every decision, ensuring we deliver solutions that make a meaningful difference in the world of clinical research.

We are committed to simplifying complex processes, eliminating obstacles to the adoption and implementation of Risk-Based Quality Management (RBQM) for all clinical trials.

We are committed to continuous improvement and innovation, ensuring our solutions remain at the forefront of technology and best practice in clinical trial quality management.

We uphold the highest standards of ethical conduct and transparency in all our operations, ensuring trust and reliability in our solutions and partnerships.

Our strength lies in our unity. We actively support one another, both within and across departments, embracing a spirit of collaboration and mutual aid. By pooling our talents and resources, we overcome challenges, innovate solutions, and achieve collective goals, strengthening our organization.

OUR TEAM

Meet the team

With a passion for innovation and a dedication to excellence, our team brings diverse expertise to every project.

Duncan Hall

Chief Executive Officer

Tammy Finnigan

Chief Operations Officer

Phil M'Caw

Chief Financial Officer

Neil Watkins

Senior Vice President, Marketing

Maya Bullen

Head of Human Resources

Tim Collard

Senior Vice President, Sales

TESTIMONIALS

RBQM Success Stories

Hear directly from our partners about how we've helped them.

Peter Benton President & CEO, Worldwide

Worldwide’s RBQM team is one of the most experienced CRO teams in the industry. This, coupled with TRI’s best-in-class technology, ensures we can proactively identify and manage risks, meaning improved quality and patient safety, and, in turn, provide a better experience for sponsors and patients.

Jeff Smith Former CEO, Alimentiv

What truly set TriTrials apart from other vendors was their unparalleled commitment to a quality deliverable helping us effectively apply a novel approach to our operations. They achieved a deep understanding of our objectives by partnering with us on a rigorous change management process which culminated in a shared vision for the integration of their risk assessment and central monitoring solution.

Amandeep Sonik Senior Director, RBQM, Worldwide

The Worldwide Clinical Trials team is pleased with our continued partnership with TRI and we are excited about the milestone of having 150 clinical trials in TRI's Risk-Based Quality Management platform. This is a key benefit for our customers as it improves data quality, trial efficiency, and patient safety.

Kelly Parish Holladay AD, RBQM, Worldwide

It has been such a wonderful ride with our TRI partners over the last few years developing our RBQM strategy with our Sponsors and Worldwide Clinical Trials Teams! We love working with everyone at TRI and look forward to bigger and better things to come!

RBQM NEWS

Clinical trial quality news and views

Subscribe to get the latest RBQM insights sent to your mailbox.

Risk-Based Clinical Data Management Takes Center Stage at SCDM 2024

Risk-Based Clinical Data Management Takes Center Stage at SCDM 2024

The Society for Clinical Data Management (SCDM) annual conference has always been a cornerstone for clinical data professionals, but this year’s event, held in Boston from September 30th to October…

The Quality Issue – September 2024

The Quality Issue – September 2024

Welcome to this month’s Quality Issue, where we spotlight some of the most important developments in clinical research and Risk-Based Quality Management (RBQM). From transformative FDA guidance to our upcoming…

Inside the FDA’s Radical New Plan to Revolutionize Drug Development

Inside the FDA’s Radical New Plan to Revolutionize Drug Development

The FDA has just released a draft guidance, “Integrating Randomized Controlled Trials for Drug and Biological Products Into Routine Clinical Practice Guidance for Industry” aimed at transforming how Randomized Controlled…